Cancer Therapy Current Events | Cancer Therapy News | 6
|
| Page
6 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
Personalized diets may offer relief to advanced cancer patients
It is well known that cancer patients undergoing chemotherapy and radiation therapy often experience nausea and loss of appetite. But until now, few researchers have looked into why this happens and what can be done to ensure that cancer patients maintain a healthy diet during treatment. view more (2007-03-12)
Trial Seeks 'Genetic Fingerprint' for Predicting Drug Effectiveness
University of Cincinnati (UC) physician-scientists believe identifying a genetic "fingerprint" could help predict which specific therapies will be most effective for patients with gastric cancer. view more (2007-10-04)
Treatment-induced growth factor causes cancer progression
In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment. view more (2007-04-06)
Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others
The antidiabetic medication metformin is associated with a reduced risk of pancreatic cancer in diabetics, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. view more (2009-08-03)
Prostate cancer patients disease free after 5 years likely to be disease free after 10 years
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years. view more (2009-07-06)
Tumors stopped from spreading to new sites
For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. view more (2007-04-06)
UC Davis researchers shed new light on how chemotherapy-induced leukemia develops
Topoisomerase II inhibitors are among the most successful chemotherapy drugs used to treat human cancer. view more (2005-11-16)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return. view more (2007-05-07)
Decrease in breast cancer incidence linked to drop in hormone replacement
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI) and the ensuing drop in hormone-replacement... view more... (2007-04-19)
Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team's analysis of several trial results. view more (2007-11-12)
New radiation technique can greatly reduce painful skin burns in women with breast cancer
Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy. view more (2006-11-07)
Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1
Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of... view more... (2008-08-22)
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
Radiation therapy prolongs life in men with recurrent prostate cancer
Men whose tumors recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence. view more (2008-06-18)
TARGETED BONE THERAPY COULD IMPROVE SURVIVAL OUTCOME FOR PATIENTS WITH ADVANCED PROSTATE CANCER (pp 326, 336)
Patients responding to chemotherapy for advanced prostate cancer could have increased survival times if specific therapy is targeted at sites of skeletal metastases, concludes research published in this week’s issue of THE LANCET. Prostate cancer tends to spread to the bones, and there is a direct relation between the extent of bone... view more... (2001-01-31)
Should older men be screened for prostate cancer?
Screening for prostate cancer in older men has been problematic. While this form of cancer can be fatal, it often progresses so slowly that men are more likely to die from some other disease. Aggressive treatments such as radical prostatectomy or radiation therapy may eradicate the cancer but have negativ view more (2006-05-02)
Double binding sites on tumor target may provide future combination therapy
Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer. view more (2008-04-09)
Newly Identified Gene Activated In 80% Of Breast Cancer Patients
New research, published this week in Breast Cancer Research, could provide a genetic explanation for breast cancer. A George Washington University Medical Center team, led by Patricia Berg, has discovered that the gene BP1 is activated in 80% of breast cancer patients. The researchers believe that this gene may offer a useful new target for early... view more... (2003-04-25)
Laser therapy can aggravate skin cancer
High irradiances of low-level laser therapy (LLLT) should not be used over melanomas. view more (2009-11-20)
|
|
| Page
6 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
|
